{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:57:27Z","timestamp":1740142647603,"version":"3.37.3"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: The role of interleukins, such as IL-17 and IL-34, in the pathogenesis of autoimmune diseases has been established in the literature. In the current study, we aimed to identify the concentrations of IL-17 (IL-17A, IL-17F) and IL-34 in the cerebrospinal fluid (CSF) of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and acute inflammatory demyelinating neuropathy (AIDN).  METHODS: We included in this study 8 patients with CIDP (none of them receiving immunomodulatory or immunosuppressant therapy), 7 patients with Guillain-Barre syndrome (GBS, AIDN), and 7 control subjects. The CIDP and AIDN diagnoses were made by clinical evaluation and electrophysiological investigations according to international criteria. CSF samples were obtained appropriately, and the levels of IL-17A, IL-17F, and IL-34 were measured by ELISA kits.  RESULTS: The concentrations of IL-17A, IL-17F, and IL-34 were higher in those with CIDP and AIDN compared to the controls (p=0.005, p=0.01, and p=0.001, respectively). While IL-34 levels were significantly higher in AIDN patients than in CIDP patients (p=0.04), there were no significant differences between the AIDN and CIDP groups with regard to the levels of IL-17A and IL-17F (p=0.4 and p=0.2, respectively)  CONCLUSION: Our results indicate that IL-17A, IL-17F, and IL-34 levels may have a role in CIDP and AIDN. Furthermore, the difference in the IL-34 levels of patients with AIDN and CIDP may indicate an important difference between the pathogenesis of these two sets of the disease.<\/jats:p>","DOI":"10.1590\/1806-9282.66.11.1583","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:41:49Z","timestamp":1606948909000},"page":"1583-1588","source":"Crossref","is-referenced-by-count":2,"title":["A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1590","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-3768","authenticated-orcid":false,"given":"Hayriye","family":"Soyt\u00fcrk","sequence":"first","affiliation":[{"name":"Bolu Abant Izzet Baysal University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5308-4653","authenticated-orcid":false,"given":"Murat","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Bolu Abant Izzet Baysal University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,11]]},"reference":[{"issue":"24","key":"ref1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes PA","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis","volume":"48","author":"Asbury AK","year":"1969","journal-title":"Medicine (Baltimore)"},{"issue":"(Suppl)","key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barr\u00e9 syndrome","volume":"9","author":"Prineas JW","year":"1981","journal-title":"Ann Neurol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cyto.2015.01.030","article-title":"Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease","volume":"75","author":"Sun L","year":"2015","journal-title":"Cytokine"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy linical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn RJ","year":"1989","journal-title":"Arch Neurol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes RA","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller H","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0022-510X(94)90070-1","article-title":"Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves","volume":"127","author":"Matsumuro K","year":"1994","journal-title":"J Neurol Sci"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s004010050941","article-title":"Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"96","author":"Rizzuto N","year":"1998","journal-title":"Acta Neuropathol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama Y","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","article-title":"Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Chi LJ","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"10","key":"ref13","article-title":"Predicting the response to intravenous immunoglobulins in an animal model of chronic neuritis","volume":"11","author":"Horste GMZ","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2004.10.001","article-title":"Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF","volume":"228","author":"Mei FJ","year":"2005","journal-title":"J Neurol Sci"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1179\/1743132812Y.0000000074","article-title":"Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients","volume":"34","author":"Rentzos M","year":"2012","journal-title":"Neurol Res"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","article-title":"Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barr\u00e9 syndrome","volume":"34","author":"Han RK","year":"2014","journal-title":"J Clin Immunol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/08923973.2012.697469","article-title":"Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barr\u00e9 syndrome","volume":"34","author":"Liang SL","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5877","key":"ref18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin H","year":"2008","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cyto.2017.08.020","article-title":"Interleukin 34, from pathogenesis to clinical applications","volume":"99","author":"Baghdadi M","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision","volume":"17","author":"Van den Bergh PY","year":"2010","journal-title":"Eur J Neurol"},{"issue":"(Suppl)","key":"ref21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury AK","year":"1990","journal-title":"Ann Neurol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41598-017-18433-4","article-title":"IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential","volume":"8","author":"Boulakirba S","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.20120412","article-title":"Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival","volume":"210","author":"Luo J","year":"2013","journal-title":"J Exp Med"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ajpath.2011.06.011","article-title":"Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-\u03b2 neurotoxicity","volume":"179","author":"Mizuno T","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2012.08.071","article-title":"TGF-\u03b2 induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid \u03b2 neurotoxicity","volume":"529","author":"Ma D","year":"2012","journal-title":"Neurosci Lett"},{"issue":"9","key":"ref26","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin W","year":"2013","journal-title":"Emerg Microbes Infect"},{"key":"ref27","first-page":"260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barr\u00e9 syndrome","volume":"2012","author":"Li S","year":"2012","journal-title":"Mediators Inflamm"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v66n11\/1806-9282-ramb-66-11-1583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:27:03Z","timestamp":1611448023000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302020001101583&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["S0104-42302020001101583"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.66.11.1583","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}